Application 1054
Hyperbaric oxygen therapy for the treatment of non-healing, refractory wounds in non-diabetic patients and refractory soft tissue radiation injuries
Hyperbaric oxygen therapy for the treatment of non-healing, refractory wounds in non-diabetic patients and refractory soft tissue radiation injuries
Application No. | 1054 |
| Application Name | Hyperbaric oxygen therapy for the treatment of non-healing, refractory wounds in non-diabetic patients and refractory soft tissue radiation injuries |
| Advisory Panel | Professor Peter Phelan (Chair and MSAC member) Mr Stephen Blamey (MSAC member) Dr Michael Bennett (Australian and New Zeland Hyperbaric Medicine Group nominee) Dr Michael Leung (co-opted member) Professor Lester Peters (co-opted member) Dr John Quinn (co-opted member) Dr David Smart (co-opted member) Dr Ross Taylor (Royal Australian College of General Practitioners nominee) Dr David Wilkinson (co-opted member) Dr Robert Wong (Australian and New Zealand College of Anaesthetists nominee) Mrs Robin Toohey (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | 18 December 2001 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 21 may 2003 meeting. The clinical evidence was inadequate to substantiate claims that hyperbaric oxygen therapy (HBOT) was cost-effective in the treatment of refractory soft tissue injuries or non-diabetic refractory wounds. However, the MSAC recommended that as there are no effective alternative therapies and in view of the progress of local data collections and an international trial, funding for HBOT continue for MBS listed indications at current eligible sites for a further three years. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 31 August 2004 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 29 May, 2009
